MERISTEM THERAPEUTICS
Similar Organizations
Adriacell
Anti-tumor therapeutics
ImCure Therapeutics
ImCure Therapeutics
Traxion Therapeutics Inc
Traxion Therapeutics Inc
More informations about "Meristem Therapeutics"
Meristem Therapeutics - Crunchbase Company Profile & Funding
Who are Meristem Therapeutics's competitors? Alternatives and possible competitors to Meristem Therapeutics may include Adriacell, Bearstream, and ImCure Therapeutics.See details»
Orphanet: MERISTEM THERAPEUTICS S.A.
MERISTEM THERAPEUTICS S.A. institutions.detail.person.activities. Sponsor of orphan designation E-mail: [email protected]. Meristem Therapeutics S.A. …See details»
Meristem Therapeutics S.A. - Orphanet
Meristem Therapeutics S.A. Meristem Therapeutics S.A. 8 rue de Frères Lumière. 63100 CLERMONT-FERRAND . FRANCE. Phone 1: 33(0)4 73 98 68 10 Institution's website EUGT …See details»
Meristem Therapeutics SADIR - Company Profile and News
Meristem Therapeutics operates as a biotechnology company. The Company produces therapeutic recombinant plant proteins for the pharmaceutical industry. Meristem Therapeutics …See details»
Meristem Therapeutics - Drug pipelines, Patents, Clinical trials
Sep 30, 2024 · Explore Meristem Therapeutics with its drug pipeline, therapeutic area, technology platform, 6 literature.See details»
Ventria Obtains Meristem’s Recombinant Lactoferrin IP
Dec 3, 2012 · Recombinant human lactoferrin is the active ingredient in Ventria Bioscience’s lead therapeutic candidate VEN100, which is currently in clinical development for the prevention of...See details»
Meristem Therapeutics - BioPharmaLink
MERISTEM® THERAPEUTICS has developed a technological platform able to ensure the production of recombinant proteins from the gene up to production of several tons of purified …See details»
Meristem Therapeutics - Medtech Insight
May 1, 2001 · France's Meristem Therapeutics, spun out of seed producer Groupe Limagrain, is using transgenic plants to produce commercial quantities of purified protein-based …See details»
Meristem Therapeutics - Tech Stack, Apps, Patents & Trademarks
This year, Meristem Therapeutics is projected to spend $67.9K on IT, according to Aberdeen.See details»
Meristem Therapeutics - Products, Competitors, Financials, …
Meristem Therapeutics is a biotechnology company. Use the CB Insights Platform to explore Meristem Therapeutics's full profile.See details»
Ventria Bioscience Acquires Meristem Therapeutics' Recombinant ...
Dec 3, 2013 · Recombinant human lactoferrin is the active ingredient in Ventria Bioscience's lead therapeutic candidate VEN100, which is currently in clinical development for the prevention of …See details»
Ventria Bioscience Acquires Meristem Therapeutics ... - BioSpace
Dec 3, 2012 · FORT COLLINS, Colo.--(BUSINESS WIRE)--Ventria Bioscience announces the completion of an agreement under which Ventria Bioscience will wholly acquire portions of the …See details»
Recombinant lactoferrin - Meristem Therapeutics - AdisInsight
Meristem Therapeutics, in collaboration with the Centre National de la Researche Scientifique (CNRS) based in France, was originally developing recombinantSee details»
Molecular farming for new drugs and vaccines - PMC
Oct 3, 2016 · In this review, we highlight not only recent progress in molecular farming and its potential for commercial drug development and production, but also the regulatory control, …See details»
Farm family grows modified corn for pharmaceutical purposes
Meristem sought offshore growers, for fear of French GMO activists destroying genetically engineered crops, Horan says. The Horans began growing modified corn as their crop host, to …See details»
Plant molecular farming: systems and products - PMC
Meristem Therapeutics (Clermont-Ferrand, France) is advancing a maize-derived mammalian lipase through clinical trials. Very little has been published on this product but it is described on …See details»
GMO regulators still walking a tightrope - ScienceDirect
Feb 2, 2007 · Cobento and Meristem Therapeutics, two EU-based companies, might be among the first to market a human biopharmaceutical from plants (Table 1): Meristem is producing …See details»
Molecular farming for new drugs and vaccines: - EMBO reports
Jul 1, 2005 · In this review, we highlight not only recent progress in molecular farming and its potential for commercial drug development and production, but also the regulatory control, …See details»
Research programme: anticancer monoclonal antibodies
Mar 5, 2013 · Meristem Therapeutics was engaged in a research programme with an undisclosed US company to develop monoclonal antibodies based on monomeric immunoglobulin ASee details»
Recombinant gastric lipase - Meristem - AdisInsight - Springer
Feb 3, 2011 · Meristem Therapeutics was developing a recombinant mammalian gastric lipase (Merispase®). The company has developed a technology to express gastric lipase in.See details»